Development and Manufacture of Pharmaceutical Dosage Forms for Treatment of Substance Abuse Disorders
| Agency: | HEALTH AND HUMAN SERVICES, DEPARTMENT OF |
|---|---|
| State: | Federal |
| Type of Government: | Federal |
| FSC Category: |
|
| NAICS Category: |
|
| Posted Date: | Feb 17, 2026 |
| Due Date: | Mar 4, 2026 |
| Solicitation No: | 75N98026R00007SB |
| Original Source: | Please Login to View Page |
| Contact information: | Please Login to View Page |
| Bid Documents: | Please Login to View Page |
Description
APEX Accelerators are an official government contracting resource for small businesses. Find your local APEX Accelerator (opens in new window) for free government expertise related to contract opportunities.
APEX Accelerators are funded in part through a cooperative agreement with the Department of Defense.
The APEX Accelerators program was formerly known as the Procurement Technical Assistance Program (opens in new window) (PTAP).
- Contract Opportunity Type: Sources Sought (Original)
- Original Published Date: Feb 17, 2026 11:24 am EST
- Original Response Date: Mar 04, 2026 09:00 am EST
- Inactive Policy: Manual
- Original Inactive Date: Mar 04, 2026
-
Initiative:
- None
- Original Set Aside:
- Product Service Code: AN11 - HEALTH R&D SERVICES; HEALTH CARE SERVICES; BASIC RESEARCH
-
NAICS Code:
- 541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
-
Place of Performance:
USA
The National Institute on Drug Abuse (NIDA) is soliciting proposals from qualified organizations having the capability to carry out development of formulations, manufacture, quality control tests, stability studies and distribution of pharmaceutical drug products to be used in the medications development program for treating substance use disorders. Development of medications for the treatment of substance use disorders is a major mission of NIDA. Some of the potential treatment drugs currently being investigated are new chemical entities and previously approved drug substances. The Government acquires these drug substances from private industries, Government contractors/grantees, or independent investigators. This contract is to provide the Government a resource for the development and manufacture of pharmaceutical dosage forms for use in preclinical and clinical studies. Please see SSN attached.
- c/o 3WFN MSC 6012 301 N Stonestreet Ave
- Bethesda , MD 20892
- USA
- Scott Duernberger
- scott.duernberger@nih.gov
- Phone Number 3015940670
- Joshua T Lazarus
- josh.lazarus@nih.gov
- Phone Number 3018276923
- Feb 17, 2026 11:24 am ESTSources Sought (Original)
See Also
Follow Selective Harnessing of Intrinsic Neuroplasticity Engineering (SHINE) Active Contract Opportunity Notice ID
DEPT OF DEFENSE
Due by 10/09/2026
Follow Air Force - Small UAS & Asymmetric Capabilities - Commercial Solutions Opening
DEPT OF DEFENSE
Due by 9/03/2027
Follow CLASS ACT Active Contract Opportunity Notice ID HQ084526SC002 Related Notice Department/Ind. Agency
DEPT OF DEFENSE
Follow SBIR FY26 Phase I Broad Agency Announcement Active Contract Opportunity Notice ID
ENVIRONMENTAL PROTECTION AGENCY
Due by 11/08/2026